Cargando…
The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro
The development of diabetic vascular complications is initiated, at least in part, by mitochondrial reactive oxygen species (ROS) production in endothelial cells. Hyperglycemia induces superoxide production in the mitochondria and initiates changes in the mitochondrial membrane potential that leads...
Autores principales: | Gerő, Domokos, Torregrossa, Roberta, Perry, Alexis, Waters, Alicia, Le-Trionnaire, Sophie, Whatmore, Jacqueline L., Wood, Mark, Whiteman, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113977/ https://www.ncbi.nlm.nih.gov/pubmed/27565382 http://dx.doi.org/10.1016/j.phrs.2016.08.019 |
Ejemplares similares
-
The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H(2)S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia
por: Pomierny, Bartosz, et al.
Publicado: (2021) -
Vasorelaxant Activity of AP39, a Mitochondria-Targeted H(2)S Donor, on Mouse Mesenteric Artery Rings In Vitro
por: da Costa Marques, Leonardo A., et al.
Publicado: (2022) -
Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway
por: Montanaro, Rosangela, et al.
Publicado: (2023) -
SLE and APS
por: Avcin, Tadej
Publicado: (2014) -
AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons
por: Zhao, Feng-li, et al.
Publicado: (2016)